Author

Kelsey M. Rife

Observed names: Kelsey M Rife, Kelsey Rife, Rife, Kelsey

Institutions: American College of Clinical Pharmacy, VA Northeast Ohio Healthcare System

Observed institutions: United States Department of Veterans Affairs, Ohio Northern University, George Washington University, Veterans Health Administration, Geriatric Research Education and Clinical Center, Louis Stokes Cleveland VA Medical Center, American College of Clinical Pharmacy, VA Northeast Ohio Healthcare System, Chillicothe VA Medical Center, Case Western Reserve University

ORCID: 0000-0002-7839-6821

Observed ORCID: 0000-0002-7839-6821

OpenAlex ID: A5058808182

Seeding pines in the Mediterranean region

2018 · Lenche Kostadinova, Carey L. Shive, et al. · REFORESTA · 46

During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy

2016 · Lenche Kostadinova, Carey L. Shive, et al. · The Journal of Infectious Diseases · 41

Professional and career development needs of clinical pharmacists in settings outside academia

2024 · Sarah M. Hayes, Donald C. Moore, et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 7

Results of a multicenter cluster-randomized controlled clinical trial testing the effectiveness of a bioinformatics-enabled pharmacist intervention in transplant recipients

2023 · David J. Taber, Ralph C. Ward, et al. · American Journal of Transplantation · 6

Remember Your MEDS: Medication Education Delivers Success

2012 · Kelsey M. Rife, Sarah E. Ginty, et al. · INNOVATIONS in pharmacy · 6

Significant HbA1c Lowering in Patients Achieving a Hepatitis C Virus Cure.

2019 · Kelsey Rife, Alessandra Lyman, et al. · Europe PMC (PubMed Central) · 5

Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled Trial

2019 · Casey L Hall, Cory E Fominaya, et al. · JMIR Research Protocols · 4

A Randomized Control Trial Testing a Medication Safety Dashboard in Veteran Transplant Recipients

2023 · David J. Taber, Sherry Milfred-LaForest, et al. · Progress in Transplantation · 3

Meeting the accreditation standard through implementation of a multiprogram residency advisory committee and ongoing quality improvement

2024 · Kelsey M Rife, Colleen P LeHew, et al. · American Journal of Health-System Pharmacy · 2

Su1421 Impact of Proton Pump Inhibitors on Achieving SVR from 8 Week Course of Ledipasvir/Sofosbuvir

2016 · Vanessa Marshall, Amy A. Hirsch, et al. · Gastroenterology · 2

Exercising empathy: Pharmacists possess skills to increase coronavirus vaccine confidence

2021 · Ukwen Akpoji, Mary Ellen Amos, et al. · Journal of the American Pharmacists Association · 1

Treating Hepatitis C Virus Reinfection With 8 Weeks of Ledipasvir/Sofosbuvir Achieves Sustained Virologic Response

2021 · Kelsey Rife · Federal Practitioner

No Significant Differences in SVR Rates for African Americans (AA) vs. Non-AA with an 8 Week Treatment Course of Ledipasvir/Sofosbuvir (LDV/SOF) in HCV

2017 · Vanessa Marshall, Perica Davitkov, et al. · Gastroenterology

Appropriately Managed Proton Pump Inhibitor (PPI) Use does not Reduce Sustained Virologic Response with Ledipasvir/Sofosbuvir (LDV/SOF)

2017 · Yasser Alsamman, Perica Davitkov, et al. · Gastroenterology

Works count: 17

Citation count: 123

H-index: 5

I10-index: 2